Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.5.0, while the previous revision v3.4.3 is no longer listed.
    Difference
    0.1%
    Check dated 2026-03-19T23:54:50.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-05T18:52:46.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - The record history shows a new revision v3.4.2 added and v3.4.1 removed, indicating a minor update to the page’s revision history. There are no visible changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:12.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor update to the record’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:35:55.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option, green and red highlights to indicate additions and deletions, and a Revision: v3.4.0, with No FEAR Act data removal noted (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T21:22:31.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.